Muzolimine
Systematic (IUPAC) name | |
---|---|
5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4H-pyrazol-3-one | |
Clinical data | |
Legal status |
|
Identifiers | |
ATC code | C03CD01 |
PubChem | CID 41386 |
ChemSpider | 37766 |
UNII | 07Z36289ZX |
KEGG | D05093 |
Chemical data | |
Formula | C11H11Cl2N3O |
Molar mass | 272.13 g/mol |
| |
| |
(verify) |
Muzolimine is a High-ceiling loop diuretic.[1] It is a pyrazole diuretic which was used for treatment of hypertension but was withdrawn worldwide because of severe neurological side effects.[2]
Synthesis
Rxn of (1-(3,4-dichlorophenyl)ethyl)hydrazine (1) with ethyl 3-amino-3-ethoxyacrylate (2) leads to a ring-forming two-site reaction and formation of the pyrazoline diuretic agent, muzolimine (3).
References
- ↑ Wangemann, P.; Braitsch, R.; Greger, R. (1987). "The diuretic effect of muzolimine". Pflugers Archiv : European journal of physiology 410 (6): 674–676. PMID 3449804.
- ↑ Reyes, A. J.; Leary, W. P. (1993). "Clinicopharmacological reappraisal of the potency of diuretics". Cardiovascular Drugs and Therapy 7: 23–28. doi:10.1007/BF00877955. PMID 8435374.
- ↑ E. Möller et al., DE 2319278; eidem, U.S. Patent 3,957,814 (1974, 1976 both to Bayer); eidem, Experientia 33, 382 (1977).
|
This article is issued from Wikipedia - version of the Saturday, August 29, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.